ClinicalTrials.Veeva

Menu

T1 Mapping in HIV Patients With High and Low CD4+ Cell Counts

U

University Hospital Bonn (UKB)

Status

Unknown

Conditions

HIV
Heart Diseases

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

HIV-infection is associated with an increased risk for cardiovascular disease. Especially patients with low CD4+ counts have a higher incidence of structural heart disease. Myocardial T1 relaxation time, as well as T1-derived extracellular volume fraction are relatively new methods for non-invasive myocardial tissue characterization, including diffuse myocardial fibrosis.

In our study HIV-patients with high and low CD4+ counts are examined on a 3T MRI scanner (Ingenia 3T, Philips Medical, Best, Netherlands). Scanning protocol includes common SSFP sequences, STIR imaging and LGE [Late gadolinium enhancement]. All HIV patients are treated in the HIV outpatient clinic of the hospital's Internal Medicine department and have an unremarkable history of cardiac disease. Patients are recruited from all over Germany. In order to obtain reference values, a subgroup of healthy, age-matched controls is included in this study.

Aim of this study is to show differences in T1- and ECV-values in the investigated subgroups. In addition, we also want to create cut-off values for healthy and affected myocardium in asymptomatic HIV-infected patients. This study could show whether myocardial T1 mapping is a potential screening parameter for beginning heart disease as part of an HIV-infection, and whether an application in routine diagnostic is reasonable.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • chronic HIV infection
  • no known cardiac disease
  • no cardiovascular risk factors

Exclusion criteria

  • contraindications to MRI (e.g. metal implants)
  • chronic kidney disease

Trial design

100 participants in 3 patient groups

HIV patients with high CD4+ cell counts
Description:
HIV Infection, Chronic high CD4+ cell counts (\>500 /μl), No known cardiac disease
HIV patients with low CD4+ cell counts
Description:
HIV Infection, Chronic low CD4+ cell counts (\<200 /μl), No known cardiac disease
Control Group
Description:
No known cardiac disease.

Trial contacts and locations

1

Loading...

Central trial contact

Claas P Naehle, MD; Julian A Luetkens, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems